Sign Up to like & get
recommendations!
1
Published in 2021 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-021-05456-x
Abstract: This review aimed to provide an overview of current research into the risk factors for Graves’ ophthalmopathy (GO). To find information about the risk factors for GO, the research database PubMed was searched and relevant…
read more here.
Keywords:
risk;
graves ophthalmopathy;
research;
risk factors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-024-00930-1
Abstract: Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder observed in a substantial proportion of patients with Graves’ disease (GD), with debilitating symptoms of disfiguring, periorbital pain, dry eyes, diplopia, and even visual disturbances. Previous studies…
read more here.
Keywords:
hospital;
effect statins;
risk;
graves ophthalmopathy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Experimental eye research"
DOI: 10.1016/j.exer.2021.108813
Abstract: BACKGROUND Orbital compartments harbor a variety of tissues that can be independently targeted in a plethora of disorders resulting in sight-threatening risks. Orbital inflammatory disorders (OID) including Graves' ophthalmopathy, sarcoidosis, IgG4 disease, granulomatosis with polyangiitis,…
read more here.
Keywords:
graves ophthalmopathy;
inflammatory disorders;
disease;
including graves ... See more keywords
Photo from archive.org
Sign Up to like & get
recommendations!
1
Published in 2020 at "International Journal of Osteopathic Medicine"
DOI: 10.1016/j.ijosm.2020.01.002
Abstract: Abstract Grave's ophthalmopathy (GO), also known as Basedowian ophthalmopathy, is common and present in about 25–50% of Graves' disease patients. Graves' disease is an autoimmune disorder leading to excess thyroid hormone production. Patients may present…
read more here.
Keywords:
osteopathic approach;
graves ophthalmopathy;
approach graves;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-87126-0
Abstract: Graves’ ophthalmopathy (GO) with elevated IgG4 levels has different characteristics from patients with GO who do not have elevated IgG4 levels, but the study findings are contradictory. The goal of this study was first to…
read more here.
Keywords:
igg;
graves ophthalmopathy;
igg4 igg;
study ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Bioscience Reports"
DOI: 10.1042/bsr20202072
Abstract: Abstract The macrophage migration inhibitory factor (MIF)/cluster of differentiation 74 (CD74) plays a role in immunological functions. The present study aims to investigate whether single-nucleotide polymorphisms (SNPs) in the MIF and CD74 are risk factors…
read more here.
Keywords:
differentiation;
cluster differentiation;
cd74;
graves disease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cornea"
DOI: 10.1097/ico.0000000000002404
Abstract: PURPOSE To characterize meibomian glands (MGs) features in patients with Graves ophthalmopathy (GO) by in vivo confocal microscopy (IVCM) and to further investigate possible correlations with ocular surface characteristics. METHODS Consecutive patients with GO and…
read more here.
Keywords:
microscopy;
vivo confocal;
patients graves;
meibomian glands ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000018242
Abstract: BACKGROUND Graves ophthalmopathy (GO) is one of the remaining enigmas in thyroidology. Glucocorticoids (GCs) are strongly recommended but their effects are not completely satisfactory and adverse reactions can occur. Tripterygium glycosides (TG) is a promising…
read more here.
Keywords:
graves ophthalmopathy;
efficacy safety;
tripterygium;
efficacy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-053173
Abstract: Introduction Intravenous glucocorticoids pulse therapy is the first-line treatment for moderate-to-severe and active Graves’ ophthalmopathy, with a large proportion of patients having poor efficacy and exposed to the risk of glucocorticoids adverse effects. We introduce…
read more here.
Keywords:
glucocorticoids pulse;
intravenous glucocorticoids;
pulse therapy;
graves ophthalmopathy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "International Journal of Endocrinology"
DOI: 10.1155/2019/7065713
Abstract: Purpose Graves' ophthalmopathy (GO) is the most common extra-thyroid manifestation of Graves' disease (GD). The Clinical Activity Score (CAS) has been widely used to evaluate GO inflammation severity and response to treatment; however, it is…
read more here.
Keywords:
graves ophthalmopathy;
infrared thermography;
upper eyelids;
cas ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Endocrinology"
DOI: 10.1155/2019/7429187
Abstract: The objective of this study was to investigate whether IRF7 polymorphisms are associated with autoimmune thyroid diseases (AITDs). We selected three single nucleotide polymorphisms (SNPs) of IRF7, namely, rs1061501, rs1131665, and rs1061502 for genotyping using…
read more here.
Keywords:
graves ophthalmopathy;
thyroid diseases;
autoimmune thyroid;
gene ... See more keywords